The content on this site is intended for healthcare professionals only
Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Olaparib induces tumour response as single agent in BRCA-deficient breast cancer
Dr Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London,...
3 Jul 2009
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast c...
Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US
3 Jul 2009
Therapeutic vaccine improves response rate and extends progression-free survival...
Dr Patrick Hwu - M.D. Anderson Cancer Center, US
3 Jul 2009
Bortezomib based therapies for myeloma
Dr Paul Richardson - Hematologic Oncology Dept, Dana-Farber Cancer Institute
2 Jul 2009
Therapeutic cancer vaccine significantly prolongs disease-free survival for foll...
Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA
2 Jul 2009
PARP inhibitors show promise for hard-to-treat breast cancers
Dr. Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London...
25 Jun 2009
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland
25 Jun 2009
PSA/Prostate screening
Dr. Otis W. Brawley - Chief Medical Officer, ASCO
25 Jun 2009
Cancer prevention strategies
Professor Peter Boyle, International Prevention Research Institute
25 Jun 2009
Zoledronic acid for treament of prostate cancer
Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals
25 Jun 2009
ASCO: Patient accrual in clinical trials
Steven K. Cheng, PhD - Oregon Health and Science University, Oregan, USA
22 Jun 2009
ASCO: Prophylactic creams and antibiotics reduce severe drug-related skin rash
Dr. Edith Mitchell, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
22 Jun 2009